A detailed history of Reynders Mc Veigh Capital Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Reynders Mc Veigh Capital Management, LLC holds 87,974 shares of JNJ stock, worth $12.8 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
87,974
Previous 90,561 2.86%
Holding current value
$12.8 Million
Previous $13.2 Million 7.71%
% of portfolio
0.76%
Previous 0.75%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $376,356 - $433,012
-2,587 Reduced 2.86%
87,974 $14.3 Million
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $523,955 - $572,583
-3,629 Reduced 3.85%
90,561 $13.2 Million
Q1 2024

May 07, 2024

SELL
$155.22 - $162.74 $285,139 - $298,953
-1,837 Reduced 1.91%
94,190 $14.9 Million
Q4 2023

Feb 07, 2024

SELL
$145.6 - $158.88 $481,790 - $525,733
-3,309 Reduced 3.33%
96,027 $15.1 Million
Q3 2023

Nov 09, 2023

SELL
$155.75 - $174.48 $453,699 - $508,260
-2,913 Reduced 2.85%
99,336 $15.5 Million
Q2 2023

Aug 09, 2023

BUY
$154.35 - $166.11 $571,249 - $614,773
3,701 Added 3.76%
102,249 $16.9 Million
Q1 2023

May 03, 2023

SELL
$151.05 - $180.26 $427,018 - $509,595
-2,827 Reduced 2.79%
98,548 $15.3 Million
Q4 2022

Feb 10, 2023

SELL
$160.2 - $179.79 $1.08 Million - $1.21 Million
-6,749 Reduced 6.24%
101,375 $17.9 Million
Q3 2022

Nov 08, 2022

SELL
$161.33 - $179.52 $627,412 - $698,153
-3,889 Reduced 3.47%
108,124 $17.7 Million
Q2 2022

Aug 05, 2022

SELL
$168.19 - $186.01 $491,787 - $543,893
-2,924 Reduced 2.54%
112,013 $19.9 Million
Q1 2022

May 11, 2022

SELL
$158.14 - $179.59 $47,600 - $54,056
-301 Reduced 0.26%
114,937 $20.4 Million
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $382,340 - $424,220
-2,452 Reduced 2.08%
115,238 $19.7 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $229,976 - $255,565
-1,424 Reduced 1.2%
117,690 $19 Million
Q2 2021

Aug 12, 2021

SELL
$159.48 - $171.07 $295,516 - $316,992
-1,853 Reduced 1.53%
119,114 $19.6 Million
Q1 2021

May 07, 2021

SELL
$153.07 - $170.48 $284,097 - $316,410
-1,856 Reduced 1.51%
120,967 $19.9 Million
Q4 2020

Feb 10, 2021

BUY
$137.11 - $157.38 $202,648 - $232,607
1,478 Added 1.22%
122,823 $19.3 Million
Q3 2020

Oct 28, 2020

SELL
$140.38 - $153.83 $192,180 - $210,593
-1,369 Reduced 1.12%
121,345 $18.1 Million
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $395,704 - $477,726
3,072 Added 2.57%
122,714 $17.3 Million
Q1 2020

May 13, 2020

SELL
$111.14 - $153.99 $1.55 Million - $2.15 Million
-13,979 Reduced 10.46%
119,642 $15.7 Million
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $3.51 Million - $4.04 Million
-27,557 Reduced 17.1%
133,621 $19.5 Million
Q3 2019

Nov 08, 2019

SELL
$126.95 - $142.14 $2.45 Million - $2.74 Million
-19,305 Reduced 10.7%
161,178 $20.9 Million
Q2 2019

Aug 06, 2019

SELL
$131.15 - $144.24 $2.52 Million - $2.77 Million
-19,217 Reduced 9.62%
180,483 $25.1 Million
Q1 2019

May 10, 2019

SELL
$125.72 - $139.79 $2.78 Million - $3.09 Million
-22,091 Reduced 9.96%
199,700 $27.9 Million
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $302,800 - $364,425
-2,465 Reduced 1.1%
221,791 $28.6 Million
Q3 2018

Nov 26, 2018

BUY
$121.58 - $142.88 $299,208 - $351,627
2,461 Added 1.11%
224,256 $31 Million
Q2 2018

Aug 09, 2018

BUY
$119.4 - $131.76 $67,819 - $74,839
568 Added 0.26%
221,795 $26.9 Million
Q1 2018

Jul 26, 2018

BUY
$125.1 - $148.14 $24.1 Million - $28.6 Million
192,877 Added 680.34%
221,227 $28.4 Million
Q1 2018

May 03, 2018

SELL
$125.1 - $148.14 $22.1 Million - $26.2 Million
-176,539 Reduced 86.16%
28,350 $221 Million
Q4 2017

Feb 06, 2018

SELL
$131.22 - $143.62 $1.79 Million - $1.96 Million
-13,617 Reduced 6.23%
204,889 $0
Q3 2017

Nov 09, 2017

BUY
$129.47 - $135.38 $490,043 - $512,413
3,785 Added 1.76%
218,506 $28.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
214,721
214,721 $28.4 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $380B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Reynders Mc Veigh Capital Management, LLC Portfolio

Follow Reynders Mc Veigh Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.